About the Authors

Tobias Reichmuth

tobias@maximon.com (TR); collin-ewald@ethz.ch (CYE)

Affiliation Maximon AG, Zug, Switzerland

Collin Y. Ewald

tobias@maximon.com (TR); collin-ewald@ethz.ch (CYE)

Affiliation Laboratory of Extracellular Matrix Regeneration, Institute of Translational Medicine, Department of Health Sciences and Technology, Swiss Federal Institute of Technology (ETH Zürich), Schwerzenbach, Switzerland

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests:TR is a co-founder and shareholder of Maximon AG. CYE is a co-founder and shareholder of Avea Life AG, and is on the Scientific Advisory Board of Maximon AG.